Computational prediction of therapeutic response and cancer outcomes
Griffiths, M.; Kubeyev, A.; Laurie, J.; Giorni, A.; Zillmann da Silva, L. A.; Sivasubramaniam, P.; Foster, M. T.; Biankin, A. V.; Asghar, U. S.
Show abstract
Oncology therapeutic development continues to be plagued by high failure rates leading to substantial costs with only incremental improvements in overall benefit and survival. Advances in technology including the molecular characterisation of cancer and computational power provide the opportunity to better model therapeutic response and resistance. Here we use a novel approach which utilises Bayesian statistical principles used by astrophysicists to measure the mass of dark matter to predict therapeutic response. We construct "Digital Twins" of individual cancer patients and predict response for cancer treatments. We validate the approach by predicting the results of clinical trials. Better prediction of therapeutic response would improve current clinical decision-making and oncology therapeutic development.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Machine learning and mechanistic modeling for prediction of metastatic relapse in breast cancer 94%
- Histology-based Prediction of Therapy Response to Neoadjuvant Chemotherapy for Esophageal and Esophagogastric Junction Adenocarcinomas Using Deep Learning 93%
- Simple Linear Cancer Risk Prediction Models with Novel Features Outperform Complex Approaches 92%
Similar papers in this journal
- A Scoping Review of Artificial Intelligence Applications in Clinical Trial Risk Assessment 94%
- Federated Target Trial Emulation using Distributed Observational Data for Treatment Effect Estimation 93%
- Cross-Platform Omics Prediction procedure enables precision medicine in patients with stage-III melanoma 91%
Similar papers in this journal
- Clinical interpretation of integrative molecular profiles to guide precision cancer medicine 95%
- Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence 94%
- Additivity predicts the efficacy of most approved combination therapies for advanced cancer 94%
Similar papers in this journal
- Trends in Phase II trials for cancer therapies 93%
- Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanoma 92%
- Decoding the JAK-STAT axis in colorectal cancer with AI-HOPE-JAK-STAT: A conversational artificial intelligence approach to clinical-genomic integration 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.